Viking Therapeutics, Inc. (VKTX)
28.99
+2.15
(+8.01%)
USD |
NASDAQ |
Nov 09, 16:00
29.00
+0.01
(+0.03%)
After-Hours: 17:11
Viking Therapeutics Gross Profit (Annual) : -0.431M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.431M |
| December 31, 2024 | -0.346M |
| December 31, 2023 | -0.292M |
| December 31, 2022 | -0.291M |
| December 31, 2021 | -0.296M |
| December 31, 2020 | -0.277M |
| December 31, 2019 | -0.26M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Eli Lilly & Co. | 54.13B |
| Ironwood Pharmaceuticals, Inc. | 294.27M |
| Compass Therapeutics, Inc. | -1.472M |
| Structure Therapeutics, Inc. | -3.899M |
| Amgen, Inc. | 26.01B |